Webinar on Myriad and Monsanto

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Webinar on Myriad and Monsanto

Managing IP’s next webinar is on topical biotech patent developments in the United States, and takes place on Thursday June 27 at 5pm BST/noon EDT

Produced in association with LexisNexis, the webinar features Lawrence M Sung of BakerHostetler, Eric Bensen of Vandenburg & Feliu and Heather Boussios of Emergent BioSolutions.

The speakers will discuss last week’s US Supreme Court decision in the Myriad case on patentability of DNA as well as the recent decision in Monsanto regarding patent exhaustion. They will also touch on other recent and pending developments.

Participation in the webinar is free and listening live earns 1 CLE/CPD point per hour.

Pre-register for the webinar here: managingip.com/web-seminars.html

more from across site and SHARED ros bottom lb

More from across our site

The combined firm, which has a newly appointed IP partner in London, brings together more than 3,500 practitioners across 52 offices, with flagship hubs in Seattle, London, Sydney and New York
A host of SEP-rich law firms, both leading arguments and as intervenors, are set to feature in the UK Supreme Court’s third FRAND episode, though one ground of appeal has been settled
Law firms are investing in generative engine optimisation and boosting their online presence in the hope of gaining a new client base
A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Gift this article